| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f255f4e7672286414bee614d7c777e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79e62b64348d61658ebf10330bb0b74b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bc16ff8b0a00f42578dba3da282f865
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26514fdcb7ecda81190de8371dbba9e4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N33-02 |
| filingDate |
2012-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b578ab365ac64f0626b9dbb635b00a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a19f8cfe2fe8bf0a5277f15b8af8ac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7db7e8502680dfcea6490f5d9b90f7e8 |
| publicationDate |
2014-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8916587-B1 |
| titleOfInvention |
Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder |
| abstract |
A pharmaceutical composition comprising a drug substance consisting essentially of a pharmaceutically acceptable organic acid addition salt of an amine containing pharmaceutically active compound wherein the amine containing pharmaceutical active compound is selected from the group consisting of racemic or single isomer ritalinic acid or phenethylamine derivatives and the drug substance has a physical form selected from amorphous and polymorphic. |
| priorityDate |
2007-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |